MedMesh.i
Curation
PubMed
Racine
Curation
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Catechols »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Catecholamines < Catechols < Cathepsin D  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000742 (2013) Hélène Pouclet [France] ; Pascal Derkinderen ; Thibaud LebouvierFoot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
000862 (????) Olivier Rascol [France] ; Paolo Barone ; Madhuri Behari ; Murat Emre ; Nir Giladi ; C Warren Olanow ; Evzen Ruzicka ; Francesco Bibbiani ; David Squillacote ; Anna Patten ; Eduardo TolosaPerampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.
000951 (2011) O. Rascol [France]Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
000970 (2011) Jean-Christophe Corvol [France] ; Cécilia Bonnet ; Fanny Charbonnier-Beaupel ; Anne-Marie Bonnet ; Marie-Hélène Fiévet ; Agnès Bellanger ; Emmanuel Roze ; Gayané Meliksetyan ; Mouna Ben Djebara ; Andreas Hartmann ; Lucette Lacomblez ; Cédric Vrignaud ; Noël Zahr ; Yves Agid ; Jean Costentin ; Jean-Sébastien Hulot ; Marie VidailhetThe COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
000971 (????) David Maltête [France] ; Anne Marie Cottard ; Bruno Mihout ; Jean CostentinErythrocytes catechol-o-methyl transferase activity is up-regulated after a 3-month treatment by entacapone in parkinsonian patients.
000B93 (2009) Alain Destée [France] ; Karin Rérat ; Isabelle BourdeixIs there a difference between levodopa/ dopa-decarboxylase inhibitor and entacapone and levodopa/dopa-decarboxylase inhibitor dose fractionation strategies in Parkinson's disease patients experiencing symptom re-emergence due to wearing-off? The Honeymoon Study.
000C41 (2008) P. Damier [France] ; F. Viallet ; M. Ziegler ; I. Bourdeix ; K. ReratLevodopa/DDCI and entacapone is the preferred treatment for Parkinson's disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort.
000D51 (2007) P-P Derost [France] ; L. Ouchchane ; D. Morand ; M. Ulla ; P-M Llorca ; M. Barget ; B. Debilly ; J-J Lemaire ; F. DurifIs DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
000E78 (2005) Frédéric Libert [France] ; François Coudoré ; Damien Richard ; Franck Durif ; Alain EschalierDevelopment of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine.
000F17 (2005) Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
000F19 (????) O. Rascol [France] ; D J Brooks ; E. Melamed ; W. Oertel ; W. Poewe ; F. Stocchi ; E. TolosaRasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
001076 (2003) G. Fénelon [France] ; S. Giménez-Roldán ; J L Montastruc ; F. Bermejo ; F. Durif ; I. Bourdeix ; J-J Péré ; L. Galiano ; J. SchadrackEfficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
001097 (2003) Entacapone/levodopa/carbidopa combination tablet: Stalevo.
001229 (2001) F. Durif [France] ; I. Devaux ; J J Pere ; J C Delumeau ; I. BourdeixEfficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study.
001768 (1991) P. Horellou [France] ; C. Lundberg ; B. Le Bourdellès ; K. Wictorin ; P. Brundin ; P. Kalén ; A. Björklund ; J. MalletBehavioural effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Catechols" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Catechols" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Catechols
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024